Author
Listed:
- Jason W.-L. Eng
(Roswell Park Cancer Institute, Center for Genetics and Pharmacology)
- Chelsey B. Reed
(Roswell Park Cancer Institute, Center for Genetics and Pharmacology)
- Kathleen M. Kokolus
(Roswell Park Cancer Institute, Center for Genetics and Pharmacology)
- Rosemarie Pitoniak
(Roswell Park Cancer Institute, Center for Genetics and Pharmacology)
- Adam Utley
(Roswell Park Cancer Institute, Center for Genetics and Pharmacology)
- Mark J. Bucsek
(Roswell Park Cancer Institute, Center for Genetics and Pharmacology)
- Wen Wee Ma
(Roswell Park Cancer Institute)
- Elizabeth A. Repasky
(Roswell Park Cancer Institute, Center for Genetics and Pharmacology)
- Bonnie L. Hylander
(Roswell Park Cancer Institute, Center for Genetics and Pharmacology)
Abstract
Cancer research relies heavily on murine models for evaluating the anti-tumour efficacy of therapies. Here we show that the sensitivity of several pancreatic tumour models to cytotoxic therapies is significantly increased when mice are housed at a thermoneutral ambient temperature of 30 °C compared with the standard temperature of 22 °C. Further, we find that baseline levels of norepinephrine as well as the levels of several anti-apoptotic molecules are elevated in tumours from mice housed at 22 °C. The sensitivity of tumours to cytotoxic therapies is also enhanced by administering a β-adrenergic receptor antagonist to mice housed at 22 °C. These data demonstrate that standard housing causes a degree of cold stress sufficient to impact the signalling pathways related to tumour-cell survival and affect the outcome of pre-clinical experiments. Furthermore, these data highlight the significant role of host physiological factors in regulating the sensitivity of tumours to therapy.
Suggested Citation
Jason W.-L. Eng & Chelsey B. Reed & Kathleen M. Kokolus & Rosemarie Pitoniak & Adam Utley & Mark J. Bucsek & Wen Wee Ma & Elizabeth A. Repasky & Bonnie L. Hylander, 2015.
"Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activation,"
Nature Communications, Nature, vol. 6(1), pages 1-13, May.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7426
DOI: 10.1038/ncomms7426
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7426. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.